Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 5.21% |
| CYNOSURE INC | CYNO | 4.42% |
| DAWSON GEOPH | DWSN | 4.33% |
| MARRIOTT VAC | VAC | 3.27% |
| BLOOMIN' | BLMN | 2.93% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
•Humana (NYSE:HUM) posted second quarter earnings of $2.00, versus Zacks estimates of $1.63, on revenues of $8.65 billion, versus Zacks estimates of $8.58 billion. The company provided full-year guidance of $5.65-$5.75
•NRG Energy (NYSE:NRG) topped estimates with second quarter earnings of 81 cents up from Zacks projections of 41 cents, as revenues fell 4.6% to $2.13 billion, but were above Zacks estimates of $2.00 billion
•Loews (NYSE:L) topped projections with second quarter results of 87 cents, 5 cents higher than Zacks projections, on revenues of $3.45 billion, versus Zacks estimates of $3.39 billion
•Oshkosh Truck (NYSE:OSK) bested earnings and revenue projections with fiscal third quarter earnings of $2.31, a 39-cent beat, on a 100.7% gain in revenues to $2.43 billion, ahead of $2.29 billion estimates
•Goldman Sachs (NYSE:GS) added Meade Johnson Nutrition (NYSE:MJN) to its Conviction Buy List, with a $61 price target
•JP Morgan (NYSE:JPM) upgraded Coca-Cola (NYSE:KO) to "overweight" from "neutral," with a price target of $66
•MetLife (NYSE:MET) plans to offer 75 million shares to help finance its $6.8 billion purchase of American Life, a division of AIG (NYSE:AIG)
•A Barron's article highlighted Bank of America (NYSE:BAC) as attractive at current valuation levels, on the appeal of its banking business and brokerage activities, despite declining consumer fees. Barron's also noted a rise in Ford (NYSE:F) shares to $20 over the next year possible, following earnings gains should auto sales improve
Read the full reports :
Analyst Report on HUM
Analyst Report on NRG
Analyst Report on L
Snapshot Report on OSK
Analyst Report on GS
Snapshot Report on MJN
Analyst Report on JPM
Analyst Report on KO
Analyst Report on MET
Analyst Report on BAC
Analyst Report on F